MarketScreener Editorial Features Harmony Biosciences Holdings, Inc.
Equities
HRMY
US4131971040
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.89 USD | -0.93% |
|
+4.15% | -22.80% |
| Apr. 02 | Harmony Biosciences Holdings, Inc. Announces Management Changes | CI |
| Feb. 25 | Deutsche Bank Adjusts Harmony Biosciences PT to $30 From $31, Maintains Hold Rating | MT |
MarketScreener Editorial Features
Search
 | MarketScreener's World Press Review: January 10 | January 10, 2023 at 08:39 am EST |
 | An unusual period for stock markets | July 07, 2022 at 09:43 am EDT |
 | Analyst recommendations: Bunge, Coinbase, Ford, Morgan Stanley, Goldman Sachs... | July 07, 2022 at 05:38 am EDT |
No results for this search
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
